Seven of the 42 patients (16.7%) discontinued palbociclib treatment due to treatment‐related AEs (neutropenia in 4 patients; and malaise, alanine aminotransferase/aspartate aminotransferase increased and subarachnoid hemorrhage in 1 patient each). This evidence concerns the gene GPT and neutropenia.